Compare OKYO & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OKYO | NTIC |
|---|---|---|
| Founded | 2007 | 1970 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.7M | 86.3M |
| IPO Year | 2022 | N/A |
| Metric | OKYO | NTIC |
|---|---|---|
| Price | $1.75 | $9.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 378.8K | 5.8K |
| Earning Date | 07-18-2025 | 01-08-2026 |
| Dividend Yield | N/A | ★ 0.44% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $86,204,962.00 |
| Revenue This Year | N/A | $11.40 |
| Revenue Next Year | N/A | $8.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.03 | $6.75 |
| 52 Week High | $3.35 | $12.53 |
| Indicator | OKYO | NTIC |
|---|---|---|
| Relative Strength Index (RSI) | 39.80 | 51.32 |
| Support Level | $1.86 | $8.63 |
| Resistance Level | $2.23 | $9.44 |
| Average True Range (ATR) | 0.22 | 0.31 |
| MACD | -0.02 | -0.09 |
| Stochastic Oscillator | 18.22 | 32.58 |
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.